A planned phase Ib/IIa study of VTX 2337 in combination with gemcitabine in patients with pancreatic cancer
Latest Information Update: 25 Oct 2012
Price :
$35 *
At a glance
- Drugs Motolimod (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 24 Oct 2012 New trial record